XRAY Stock Analysis: Buy, Sell, or Hold?
XRAY - DENTSPLY SIRONA Inc.
$12.47
0.20 (1.63%)
▲
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 26, 2026
24d
Get Alerted When XRAY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called XRAY this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: XRAY shows positive signals but monitor for confirmation. Market pricing in 2.5% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: XRAY shows positive signals but monitor for confirmation. Market pricing in 2.5% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$11.15
Based on -0.7% avg growth
INTRINSIC VALUE TODAY
$6.92
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: XRAY is currently trading at $12.47, which is considered slightly high relative to its 30-day fair value range of $11.50 to $12.70. The stock's valuation (Forward PE: 8.2) is in line with its historical norms (7.6). At these levels, the market is pricing in 2.5% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, XRAY is in a downtrend. Immediate support is located at $11.95, while resistance sits at $13.03.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, XRAY is in a downtrend. Immediate support is located at $11.95, while resistance sits at $13.03.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$11.50 -
$12.70
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
61.4%
All Signals
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($13.03)
- NEUTRAL: Market pricing in 2.5% annual earnings growth - fairly valued
Fair Price Analysis
30-Day Fair Range
$11.50 -
$12.70
Current vs Fair Value
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$11.95
Resistance Level
$13.03
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
8.17
Wall Street Target
$13.03
(+4.5%)
Revenue Growth (YoY)
-4.9%
Earnings Growth (YoY)
15.2%
Profit Margin
-24.3%
Valuation Premium vs History
+2.5% premium
PE vs Historical
8.2 vs 7.6
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+2.5%
(market-implied from PE analysis)
1-Year Target
$12.78
(+3%)
2-Year Target
$13.10
(+5%)
3-Year Target
$13.43
(+8%)
3-Yr Target (if PE normalizes)
(PE: 8→8)
PE COMPRESSION
$12.50
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.3, Growth: -5.5%)
$28.77
(+131%)
Base:
(SPY PE: 8.2, Growth: -5.5%)
$10.53
(-16%)
Bear:
(PE: 6.9, Growth: -5.5%)
$8.95
(-28%)
Last updated: February 01, 2026 7:31 AM ET
Data refreshes hourly during market hours. Next update: 8:31 AM
Data refreshes hourly during market hours. Next update: 8:31 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XRAY showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$92 | 63 BUY |
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$608 | 58 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$191 | 58 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$292 | 57 HOLD |
|
ALGN
Align Technology Inc |
BUY
18 analysts |
$184 | 62 BUY |
Advanced XRAY Option Strategies
Professional options setups generated by AI based on today's XRAY price and gamma walls.
